Advertisement
Research Article

Influenza B Virus Ribonucleoprotein Is a Potent Activator of the Antiviral Kinase PKR

  • Bianca Dauber,

    Affiliation: P15, Robert Koch-Institute, Berlin, Germany

    Current address: Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Alberta, Canada

    X
  • Luis Martínez-Sobrido,

    Affiliation: School of Medicine and Dentistry, University of Rochester, Rochester, New York, United States of America

    X
  • Jana Schneider,

    Affiliation: P15, Robert Koch-Institute, Berlin, Germany

    X
  • Rong Hai,

    Affiliation: Department of Microbiology, Mount Sinai School of Medicine, New York, New York, United States of America

    X
  • Zoe Waibler,

    Affiliation: Division of Immunology, Paul Ehrlich Institut, Langen, Germany

    X
  • Ulrich Kalinke,

    Affiliation: Division of Immunology, Paul Ehrlich Institut, Langen, Germany

    X
  • Adolfo García-Sastre,

    Affiliations: Department of Microbiology, Mount Sinai School of Medicine, New York, New York, United States of America, Department of Medicine, Division of Infectious Diseases, Mount Sinai School of Medicine, New York, New York, United States of America, Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, New York, United States of America

    X
  • Thorsten Wolff mail

    WolffT@RKI.de

    Affiliation: P15, Robert Koch-Institute, Berlin, Germany

    X
  • Published: June 12, 2009
  • DOI: 10.1371/journal.ppat.1000473

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.